Skip to main content

Table 2 Cumulate incidence and hazard ratio, crude and adjusted, for hospitalization or death, with respect to socio demographic characteristics, clinical profile, and treatment received for heart failure

From: Heart failure labelled patients with missing ejection fraction in primary care: prognosis and determinants

 

Cumulate Incidence

Crude Hazard Ratio

Adjusted Hazard Ratio

Rate (%)

95% Confidence interval

HR

95% Confidence interval

HR

95% Confidence interval

Goblal incidence

37.6

36.5-38.7

    

Ejection Fraction

 Ejection Fraction>50

17.0

13.3-20.7

1

 

1

 

 Ejection Fraction <=50

27.3

22.1-32.4

1.81

1.31-2.49

1.36

0.99-1.88

 Missing Ejection Fraction

39.1

38.0-40.2

2.33

1.84-2.95

1.84

1.45-2.33

Previous hospitalization for heart failure

51.3

49.5-53.1

2.18

2.03-2.34

1.81

1.68-1.95

Gender (Male)

39.8

38.2-41.4

1.15

1.07-1.23

1.24

1.14-1.34

Age (quintiles)

 (<=71 years; reference

29.0

26.8-31.1

1

 

1

 

 72 - 78

33.3

31.2-35.5

1.14

1.02-1.28

1.03

0.91-1.16

 79 - 82

38.1

35.6-40.5

1.43

1.27-1.61

1.21

1.07-1.37

 3 - 86

41.1

38.5-43.6

1.62

1.44-1.82

1.30

1.14-1.48

 >=87

48.8

46.2-51.3

2.17

1.94-2.43

1.60

1.40-1.83

Socio economic deprivation index

 1 (less disadvantaged)

33.5

31.1-35.8

1

 

1

 

 2

36.7

34.3-39.1

1.08

0.96-1.21

1.10

0.98-1.24

 3

37.3

34.9-39.6

1.06

0.95-1.19

1.01

0.90-1.13

 4

38.6

36.2-41.0

1.11

0.99-1.25

1.03

0.92-1.16

 5 (more disadvantaged)

42.8

40.4-45.3

1.28

1.14-1.43

1.13

1.01-1.27

 Patients requiring home care

57.0

55.0-59.1

2.13

1.98-2.29

1.58

1.46-1.71

Cardiovascular risk factors

 Hypertension

38.3

37.1-39.5

1.13

1.04-1.22

1.08

0.99-1.19

 Diabetes

41.6

39.7-43.5

1.25

1.16-1.34

1.17

1.08-1.26

 Hypercholesterolemia

34.5

32.6-36.4

0.90

0.83-0.97

0.94

0.86-1.02

 Obesity

37.7

35.5-40.0

0.99

0.91-1.08

1.00

0.92-1.10

 Smoking habit

39.2

35.5-43.0

0.98

0.87-1.11

1.04

0.91-1.19

Cardiovascular diseases

 Coronary heart disease

41.5

39.4-43.6

1.21

1.12-1.31

1.11

1.02-1.21

 Atrial fibrillation

42.4

40.6-44.2

1.31

1.22-1.41

1.05

0.96-1.15

 Stroke

44.7

41.2-48.1

1.41

1.26-1.57

1.15

1.03-1.29

 Peripheral artery disease

45.4

41.0-49.8

1.45

1.27-1.66

1.11

0.97-1.28

Other comorbidities

 Chronic obstructive pulmonary disease

45.1

42.3-47.8

1.39

1.28-1.52

1.25

1.14-1.37

 Chronic renal failure

44.8

42.3-47.4

1.47

1.35-1.60

1.18

1.08-1.29

Drug therapy

 ACE inhibitor or ARB*

37.3

36.1-38.5

0.91

0.84-0.99

0.85

0.78-0.93

 Beta-blocker

37.9

35.3-40.5

1.00

0.91-1.09

1.03

0.94-1.14

 Loop diuretics

42.5

41.3-43.8

2.27

2.05-2.51

1.64

1.48-1.82

 Statins

35.1

33.6-36.6

0.87

0.81-0.94

0.85

0.79-0.93

  1. a ACE angiotensin converting enzyme, ARB Angiotensin Receptor Blocker